Page last updated: 2024-10-22

amitriptyline and Shaken Baby Syndrome

amitriptyline has been researched along with Shaken Baby Syndrome in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Shaken Baby Syndrome: Brain injuries resulted from vigorous shaking of an infant or young child held by the chest, shoulders, or extremities causing extreme cranial acceleration. It is characterized by the intracranial and intraocular hemorrhages with no evident external trauma. Serious cases may result in death.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allibe, N1
Eysseric-Guerin, H1
Kintz, P1
Bartoli, M1
Bost-Bru, C1
Grenier, F1
Scolan, V1
Stanke-Labesque, F1

Other Studies

1 other study available for amitriptyline and Shaken Baby Syndrome

ArticleYear
Amitriptyline poisoning of a baby: how informative can hair analysis be?
    Forensic science international, 2015, Volume: 249

    Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Child Abuse; Chromatography, Liquid; Drug Overdose;

2015